Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Tendera

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
European Heart Journal|February 7, 2007
Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006Javier Escaned, Lars Rydén, José Luis Zamorano, et al.
European Heart Journal|December 28, 2018
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort studyEmmanuel Sorbets, Philippe Gabriel Steg, Robin Young, et al.
European Heart Journal|August 28, 2024
Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registryGuillaume Roger, Grégory Ducrocq, Jules Mesnier, et al.
European Journal of Heart Failure|December 15, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial designJozef Bartunek, Beth Davison, Warren Sherman, et al.
International Journal of Oncology|July 3, 2010
Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cellsWojciech Wojakowski, Michal Tendera, Magda Kucia, et al.
Journal of the American College of Cardiology|April 20, 2004
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) studyJean L Rouleau, Ellen B Roecker, Michal Tendera, et al.
European Journal of Preventive Cardiology|January 13, 2022
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicitiesKoon-Hou Mak, Emmanuelle Vidal-Petiot, Robin Young, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.
Heart (British Cardiac Society)|February 23, 2019
Living alone and cardiovascular disease outcomesSumeet Gandhi, Shaun G Goodman, Nicola Greenlaw, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
European Heart Journal|February 7, 2007
Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006Javier Escaned, Lars Rydén, José Luis Zamorano, et al.
European Heart Journal|December 28, 2018
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort studyEmmanuel Sorbets, Philippe Gabriel Steg, Robin Young, et al.
European Heart Journal|August 28, 2024
Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registryGuillaume Roger, Grégory Ducrocq, Jules Mesnier, et al.
European Journal of Heart Failure|December 15, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial designJozef Bartunek, Beth Davison, Warren Sherman, et al.
International Journal of Oncology|July 3, 2010
Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cellsWojciech Wojakowski, Michal Tendera, Magda Kucia, et al.
Journal of the American College of Cardiology|April 20, 2004
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) studyJean L Rouleau, Ellen B Roecker, Michal Tendera, et al.
European Journal of Preventive Cardiology|January 13, 2022
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicitiesKoon-Hou Mak, Emmanuelle Vidal-Petiot, Robin Young, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.
Heart (British Cardiac Society)|February 23, 2019
Living alone and cardiovascular disease outcomesSumeet Gandhi, Shaun G Goodman, Nicola Greenlaw, et al.
Pageof 14